Study of Myasthenic Crisis in China
NCT04837625 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-09-21
Summary
This study is a multicenter, prospective, observational research. It will register the basic demographic information, medical history characteristics, clinical features, auxiliary examinations, treatment, outcomes of tracheal intubation/ventilator related events, and clinical outcomes of Myasthenic Crisis patients. The objectives including:
1. Obtain epidemiological data of MC in China;
2. Establish a standardized registration system for MC patients in China;
3. Explore the epidemiology, clinical characteristics, serological characteristics, clinical characteristics of MC, predisposing and predictive factors, extubation process/time, weaning/extubation outcome and predictors of clinical outcome in Chinese MC patients.
Conditions
- Myasthenia Gravis
- Myasthenic Crisis
Interventions
- OTHER
-
no interventions
no interventions
Sponsors & Collaborators
-
Huashan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- China
Study Locations
More Related Trials
-
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
NCT07146425 ·Status: RECRUITING
-
Myasthenia Gravis Registry in China
NCT06241521 ·Status: RECRUITING
-
Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)
NCT06965309 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study
NCT04941079 ·Status: UNKNOWN
-
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
NCT05214612 ·Status: RECRUITING
-
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
NCT06447597 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
Study of Telitacicept in Generalized Myasthenia Gravis
NCT05737160 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Myasthenia Gravis in the Real World
NCT04176211 ·Status: COMPLETED
-
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
NCT05332210 ·Status: COMPLETED ·Phase: PHASE3
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
NCT03597373 ·Status: UNKNOWN
-
Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis
NCT05716035 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
NCT07250750 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients
NCT05039190 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
NCT05408702 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
NCT04346888 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
NCT06064695 ·Status: RECRUITING ·Phase: NA
-
Myasthenia Gravis and Psyche
NCT03205306 ·Status: COMPLETED
-
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
NCT04590716 ·Status: COMPLETED
-
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
NCT07247279 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
NCT01727193 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3